ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) Read more about ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)
Global Anticoagulant Registry in the Field Read more about Global Anticoagulant Registry in the Field
Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia Read more about Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
Cardiovascular Inflammation Reduction Trial Read more about Cardiovascular Inflammation Reduction Trial
New York Blood Center National Cord Blood Program Read more about New York Blood Center National Cord Blood Program
Vest Prevention of Early Sudden Death Trial and VEST Registry Read more about Vest Prevention of Early Sudden Death Trial and VEST Registry
Bortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell Lymphoma Read more about Bortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell Lymphoma
Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients Read more about Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients
Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease Read more about Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia Read more about Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia